T antigen transformation reveals Tp53/RB-dependent route to PLAC1 transcription activation in primary fibroblasts

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Chen, Y ^a   Schlessinger, D ^a   Nagaraja, R ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Chromatin; Large T antigen; LXR; NCOA2; RXRa; Transcription

Indexed keywords

ANTIGEN; PLACENTA SPECIFIC 1 PROTEIN; PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; T ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION;

EID: 84884795813     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.31     Document Type: Article

References (35)

1. Cocchia M, Huber R, Pantano S, Chen EY, Ma P, Forabosco A et al. PLAC1, an Xq26 gene with placenta-specific expression. Genomics 2000; 68: 305-312.
2. Fant M, Weisoly DL, Cocchia M, Huber R, Khan S, Lunt T et al. PLAC1, a trophoblast- specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor. Mol Reprod Dev 2002; 63: 430-436. (Pubitemid 35222522)
3. Koslowski M, Sahin U, Mitnacht-Kraus R, Seitz G, Huber C, Tu reci O. A placentaspecific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. Cancer Res 2007; 67: 9528-9534. (Pubitemid 47535943)
4. Silva Jr WA, Gnjatic S, Ritter E, Chua R, Cohen T, Hsu M et al. PLAC1, a trophoblastspecific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer Immun 2007; 7: 18-27.
5. Dong X-Y, Peng J-R, Ye Y-J, Chen H-S, Zhang L-J, Pang X-W et al. Plac1 is a tumorspecific antigen capable of eliciting spontaneous antibody responses in human cancer patients. J Int Cancer 2008; 122: 2038-2043. (Pubitemid 351441193)
6. Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 2009; 15: 5323-5337.
7. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G et al. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003; 34: 292-296. (Pubitemid 36792861)
8. Chen Y, Moradin A, Schlessinger D, Nagaraja R. RXRa and LXR activate two promoters in placenta- and tumor-specific expression of PLAC1. Placenta 2011; 32: 877-884.
9. Srinivasan A, McClellan AJ, Vartikar J, Marks I, Cantalupo P, Li Y et al. The aminoterminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol Cell Biol 1997; 17: 4761-4773. (Pubitemid 27318151)
10. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249: 912-915.
11. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ et al. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 1998; 12: 95-106. (Pubitemid 28083661)
12. Zalvide J, Stubdal H, DeCaprio JA. The J domain of simian virus large T antigen is required to functionally inactivate RB family proteins. Mol Cell Biol 1998; 18: 1408-1415. (Pubitemid 28100905)
13. Oren M, Maltzman W, Levine AJ. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1981; 1: 101-110. (Pubitemid 11103325)
14. Sladek TL, Laffin J, Lehman JM, Jacobberger JW. A subset of cells expressing SV40 large T antigen contain elevated p53 levels and have an altered cell cycle phenotype. Cell Prolif 2000; 33: 115-125. (Pubitemid 30307239)
15. Brown DR, Deb S, Mun oz RM, Subler MA, Deb SP. The tumor suppressor p53 and the oncoprotein simian virus T antigen bind to overlapping domains on the MDM2 protein. Mol Cell Biol 1993; 13: 6849-6857. (Pubitemid 23321138)
16. Henning W, Rohaly G, Kolzau T, Knippschild U, Maacke H, Deppert W. MDM2 is a target of simian virus in cellular transformation and during lytic infection. J Virol 1997; 71: 7609-7618. (Pubitemid 27391703)
17. Ali SH, DeCaprio JA. Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol 2001; 11: 15-23.
18. Sullivan CS, Tremblay JD, Fewell SW, Lewis JA, Brodsky JL, Pipas JM. Species-specific elements in the large T-antigen J domain are required for cellular transformation and DNA replication by simian virus 40. Mol Cell Biol 2000; 20: 5749-5757. (Pubitemid 30482907)
19. Gjoerup O, Chao H, DeCaprio JA, Roberts TM. pRB-dependent, J domain-independent function of simian virus 40 large T antigen in override of p53 growth suppression. J Virol 2000; 74: 864-874. (Pubitemid 30036223)
20. Freed-Pastor WA, Prives C. Mutant p53: one name, many proteins. Genes Dev 2012; 26: 1268-1286.
21. Fiorentino FP, Marchesi I, Giordano A. On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape. J Cell Physiol 2013; 228: 276-284.
22. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 2001; 11: S27-S31.
23. Batsche E, Desroches J, Bilodeau S, Gauthier Y, Drouin J. Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. J Biol Chem 2005; 280: 19746-19756. (Pubitemid 41379500)
24. Jackman SM, Kong X, Fant ME. Plac1 (placenta-specific 1) is essential for normal placental and embryonic development. Mol Reprod Dev 2012; 79: 564-572.
25. Old LJ. Cancer is a somatic cell pregnancy. Cancer Immun 2007; 7: 19.
26. Pichiorri F, Suh S-S, Rocci A, De Luca L, Taccioli C, Santhanam R et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 2010; 18: 367-381.
27. Talluri S, Dick FA. Regulation of transcription and chromatin structure by pRB: here, there and everywhere. Cell Cycle 2012; 11: 3189-3198.
28. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 1993; 72: 309-324. (Pubitemid 23059403)
29. Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 2001; 8: 303-316. (Pubitemid 32831548)
30. Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, Yagi R et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005; 123: 917-929. (Pubitemid 41721036)
31. Verzi MP, Shin H, San Roman AK, Liu XS, Shivdasani RA. Intestinal master transcription factor CDX2 controls chromatin access for partner transcription factor binding. Mol Cell Biol 2013; 33: 281-292.
32. Sapin V, Ward SJ, Bronner S, Chambon P, Dolle P. Differential expression of transcripts encoding retinoid binding proteins and retinoic acid receptors during placentation of the mouse. Dev Dyn 1997; 208: 199-210. (Pubitemid 27068875)
33. Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM et al. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 2003; 3: 483-495. (Pubitemid 38340295)
34. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22: 2111-2123. (Pubitemid 34224619)
35. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993; 365: 855-859. (Pubitemid 23341031)